Opens in a new tab

Publications

UK NEQAS for Leucocyte Immunophenotyping has contributed to the scientific literature for over three decades, advancing standards in flow cytometry, molecular haemato-oncology, and external quality assessment/proficiency testing worldwide.

Our publications span consensus guidelines, interlaboratory studies, and methodological research – covering areas from CD4+ T cell counting and CD34+ stem cell enumeration to PNH testing, measurable residual disease in haematological malignancies, and chimerism monitoring after HSCT. These collaborative works reflect our commitment to improving laboratory accuracy and patient outcomes through rigorous external quality assessment.

Current trends in flow cytometry automated data analysis software

Cheung M, Campbell JJ, Whitby L, Thomas RJ, Braybrook J, Petzing J

Cytometry A. 2021 Oct;99(10):1007-1021. doi: https://doi.org/10.1002/cyto.a.24320. Epub 2021 Feb 19. PMID: 33606354

Assessment of plasma cell myeloma minimal residual disease testing by flow cytometry in an international inter-laboratory study: Is it ready for primetime use?

Scott SD, Fletcher M, Whitehouse H, Whitby L, Yuan C, Mazzucchelli S, Lin P, de Tute R, Dorwal P, Wallace PK, Tembhare P, Arroz M, Snowden JA, Chantry AD, Barnett D

Cytometry B Clin Cytom. 2019 May;96(3):201-208. doi: https://doi.org/10.1002/cyto.b.21754. Epub 2018 Dec 19. PMID: 30565840.

ICCS/ESCCA consensus guidelines to detect GPI-deficient cells in paroxysmal nocturnal hemoglobinuria (PNH) and related disorders part 4 – assay validation and quality assurance

Oldaker T, Whitby L, Saber M, Holden J, Wallace PK, Litwin V

Cytometry B Clin Cytom. 2018 Jan;94(1):67-81. doi: https://doi.org/10.1002/cyto.b.21615. PMID: 29251828.

Paroxysmal nocturnal haemoglobinuria testing in blood transfusion laboratories: do they go with the flow?

Whitby L, White J, Fletcher M, Whitby A, Milkins C, Barnett D

Transfus Med. 2018 Dec;28(6):451-456. doi: https://doi.org/10.1111/tme.12449. Epub 2017 Aug 18. PMID: 28833743

Laboratory Accuracy Improvement in the UK NEQAS Leucocyte Immunophenotyping Immune Monitoring Program: An Eleven-Year Review via Longitudinal Mixed Effects Modeling

Bainbridge J, Rountree W, Louzao R, Wong J, Whitby L, Denny TN, Barnett D

Cytometry B Clin Cytom. 2018 Mar;94(2):250-256. doi: https://doi.org/10.1002/cyto.b.21531. Epub 2017 May 16. PMID: 28480599; PMCID: PMC5677584.

Measurement of BCR-ABL1 by RT-qPCR in chronic myeloid leukaemia: findings from an International EQA Programme

Scott S, Travis D, Whitby L, Bainbridge J, Cross NCP, Barnett D

Br J Haematol. 2017 May;177(3):414-422. doi: https://doi.org/10.1111/bjh.14557. Epub 2017 Mar 14. PMID: 28295199.

Current international flow cytometric practices for the detection and monitoring of paroxysmal nocturnal haemoglobinuria clones: A UK NEQAS survey

Fletcher M, Whitby L, Whitby A, Barnett D

Cytometry B Clin Cytom. 2017 Jul;92(4):266-274. doi: https://doi.org/10.1002/cyto.b.21368. Epub 2016 Apr 18. PMID: 26934069.

Flow cytometry quality requirements for monitoring of minimal disease in plasma cell myeloma

Oldaker TA, Wallace PK, Barnett D

Cytometry B Clin Cytom. 2016 Jan;90(1):40-6. doi: https://doi.org/10.1002/cyto.b.21276. Epub 2015 Sep 4. PMID: 26201282; PMCID: PMC5404813.

Current laboratory practices in flow cytometry for the enumeration of CD 4(+) T-lymphocyte subsets

Whitby L, Whitby A, Fletcher M, Barnett D

Cytometry B Clin Cytom. 2015 Sep-Oct;88(5):305-11. doi: https://doi.org/10.1002/cyto.b.21241. Epub 2015 Jul 6. PMID: 25828263.

CD4 enumeration technologies: a systematic review of test performance for determining eligibility for antiretroviral therapy

Peeling RW, Sollis KA, Glover S, Crowe SM, Landay AL, Cheng B, Barnett D, Denny TN, Spira TJ, Stevens WS, Crowley S, Essajee S, Vitoria M, Ford N

PLoS One. 2015 Mar 19;10(3):e0115019. doi: https://doi.org/10.1371/journal.pone.0115019. PMID: 25790185; PMCID: PMC4366094.